PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Neurosurg. Author manuscript; available in PMC 2010 October 5.
Published in final edited form as:
PMCID: PMC2889623
NIHMSID: NIHMS158558

Adenosine A2A receptors in early ischemic vascular injury after subarachnoid hemorrhage

Fatima A. Sehba, Ph.D.,1,2 Rowena Flores, M.D.,1 Artur Muller, M.S.,1 Victor Friedrich, Ph.D.,2 Jiang-Fan Chen, M.D., Ph.D.,3 Gavin W. Britz, M.D.,4 H. Richard Winn, M.D.,1,2 and Joshua B. Bederson, M.D.1

Abstract

Object

The role of adenosine A2A receptors (A2AR) in the early vascular response after subarachnoid hemorrhage (SAH) is not known. In other forms of cerebral ischemia both activation and inhibition of A2AR is reported to be beneficial. However, these studies mainly used pharmacological receptor modulation and most of the agents available exhibit low specificity. We used adenosine A2A receptor knockout mice to study the role of A2AR in the early vascular response to SAH.

Method

SAH was induced in the wild type (WT; C57BL/6) and A2AR knockout mice (A2AR-KO) by endovascular puncture. Cerebral blood flow (CBF), intracranial pressure (ICP) and blood pressure (BP) were recorded, cerebral perfusion pressure (CPP) was deduced. Animals were sacrificed at 1, 3 and 6 hours after SAH or sham surgery. Coronal brain sections were immunostained for collagen-IV; major protein of basal lamina. The internal diameter of major cerebral arteries and the area fraction of collagen-IV positive microvessels (<100μm) were determined.

Results

Initial ICP rise and CPP fall at SAH induction was similar but CBF fall was significantly smaller in A2AR-KO as compared to WT cohorts. The internal diameter of major cerebral vessels decreased progressively after SAH. The extent of diameter reduction was significantly less in A2AR-KO than in WT mice. Collagen-IV immunostaining decreased progressively after SAH. The decrease was significantly less in A2AR-KO than in WT.

Conclusion

Our results demonstrate that global inactivation of A2AR decreases the intensity of the early vascular response to SAH. Early inhibition of A2AR after SAH might reduce cerebral injury.

Keywords: stroke, subarachnoid hemorrhage, mouse, microvessels, adenosine

Introduction

Cerebral injury after subarachnoid hemorrhage (SAH) is ischemic in nature. Two phases of cerebral ischemia are recognized; early (acute) ischemia which develops within the first 48 hours, and delayed ischemia with vasospasm, which develop 3–7 days later. Early ischemic brain injury after SAH accompanies small vessel injury, vasoconstriction, and reduced cerebral blood flow (CBF) and is the most important contributor to poor outcome after SAH.31

Adenosine is potent vasodilator which is implicated in CBF regulation especially in conditions, such as ischemia, which disturb supply and demand.25,37 The extracellular level of adenosine increases markedly during cerebral ischemia and is associated with vasodilation, decrease postsynaptic hyperpolarization, inhibition of free radical formation and platelet aggregation and platelet endothelial cell interaction. Adenosine receptors are G-protein coupled receptors and are found in at least four subtypes; A1, A2A, A2B, and A3. A1 and A2A receptors have been demonstrated to be mainly involved in adenosine mediated neuroprotection although role of A2B receptors cannot be rolled out.6 A1 and A2A receptors have high and low affinity respectively for adenosine and when activated result, in most circumstances, in opposing functions. Interaction/cross talk between A1 and A2A receptors is established and lead to A2A induced desensitization and down regulation of A1 receptors and its response.11,19 In addition adenosine receptors also make functionally active dimers with each other (e.g. A1/A2A heteromers) or with other neurotransmitter receptors (e.g. A2A/D2 heteromers).12 Thus, the capacity of adenosine to activate receptors with opposing functions allows it to serve as an upstream regulator that fine-tunes and integrates excitatory and inhibitory functions in the CNS.

Adenosine2A receptors are located on smooth muscle of cerebral vasculature and are considered prime mediators of adenosine associated vasodilation.21 In addition, A2A receptors agonists in endotoxemia and sepsis decrease inflammation and increase survival.23,36 Studies show that adenosine mediated vasodilation is impaired 48 hours after SAH8 and early administration of A2A agonist prevents development of delayed cerebral vasospasm.18 However, if A2A receptor plays a role during the early pathophysiology of SAH is not determined and studies on the role of A2A receptor in other forms of ischemic brain injury have not reached a consensus.10 Using mainly pharmacological modulation, many investigators report activation and equally many inhibition of A2A receptors to be beneficial against ischemic brain injury. Differences in the route of administration of drugs as well as the low specificity of A2A receptor agonist and antagonists may underlie this controversy.10,24

We here address this problem by comparing the effects of SAH on wild type and adenosine A2AR-knockout (KO) mice.9 SAH was induced via endovascular puncture, an adaptation of the existing rat model.4 Intracranial pressure, cerebral blood flow and blood pressure responded to SAH identically in the two populations. The internal diameter of major cerebral vessels and area fraction of collagen IV in parenchymal vessels decreased after SAH in both WT and A2AR-KO mice. However, the decrease was significantly less and developed at slower pace in A2AR-KO. Our results indicate that the absence of functional adenosine A2A receptors attenuates the intensity and slows the development of early vascular injury after SAH.

Materials and Methods

All experimental procedures and protocols used were approved by the Animal Care Committee of the Mount Sinai Medical Center. Wild-type and A2A receptor C57Bl/6 mice (20–25gm) were used. The A2A receptor knockout mice were generated by Chen et al.9 Homozygous A2A knockout mice and C57Bl/6 wild-type mice were generated by homozygous interbreeding using the breeding pairs from the University of Virginia (Joel Linden). Since this breeding strategy bypasses the need for genotyping by polymerase chain reaction or Southern analyses, the genotype of this breeding was confirmed by a functional test by using the A2A receptor agonist CGS 21680 for hypotension response (not shown). In addition, breeding was limited to 3–5 generations in order to limit the potential confounding effect of spontaneous regression resulting from the interbreeding.

Endovascular mouse model of SAH

SAH was induced using an adaptation of the rat endovascular model of SAH.4 Mice were anesthetized with ketamine-xylazine (80mg/Kg+10mg/Kg; IP), transorally intubated, ventilated, and maintained on inspired isoflourane (1% to 2% in oxygen-supplemented room air). Mice were placed on a homeothermic blanket to maintain body temperature at 37°C and positioned in a stereotactic frame. The femoral artery was cannulated for blood gas and blood pressure monitoring. For ICP measurement, the atlanto-occipital membrane was exposed and cannulated, and the cannula was affixed with methymethacrylate cement to a stainless steel screw, implanted in the occipital bone. CBF was measured by laser-Doppler flowmetry by placing 0.8mm diameter needle probes (Vasamedics, Inc., St. Paul, MN,USA) directly over the skull away from large pial vessels in the distribution of the middle cerebral artery. This variation of our original SAH model is adopted to minimize injury.

SAH was induced by advancing a 5′0 polydioxanone monofilament retrograde through the ligated right external carotid artery and distally through the internal carotid artery (ICA) until the suture perforated the intracranial ICA bifurcation. This event was confirmed by a rapid rise in ICP and bilateral fall in CBF.4 Shams that received same surgical procedure as SAH animals expect for intracranial ICA perforation were used as controls. Mice were sacrificed at 1, 3 or 6 hours after SAH or sham surgery (n=4–5 per group per time point). SAH mortality in this study was 35%.

Characterization of the mouse endovascular model of SAH

Physiological measurements

To determine if mouse SAH mimics the human SAH, physiological changes upon SAH induction were recorded. These real time recordings included blood pressure (BP), intracranial pressure (ICP) and cerebral blood flow (CBF, ipsilateral and contralateral) recording (PolyView software; Grass Instruments; MS, USA) starting 20 minutes prior to 10 or 60 minutes after SAH induction. Cerebral perfusion pressure (CPP) was calculated by subtracting ICP from BP. CBF data were normalized to the baseline value averaged over 20 minutes prior to SAH, and expressed as a percentage of baselines. The variations in the peek ICP and CBF nadir values upon SAH induction were used to evaluate the consistency and reproducibility of the model.

Histological measurements, Brain preparation

These measurements studied the affect of SAH on major vessels and on parenchymal vessels. Briefly, animals were sacrificed by perfusion with chilled saline followed by 1% paraformaldehyde (PAF). Brains were removed with the meninges and the circle of Willis intact, embedded in Tissue-Tek OCT compound (Miles, Elkhart, IN), and frozen in 2-methylbutane cooled in dry ice. Sections located at bregma +0.0 to 0.38 mm and +0.38 to 0.74 mm were used. (www.mlb.org)

Collagen-IV Immunofluorescence

Collagen IV (constitutes up to 90% of the total protein of the basal lamina and confers structural integrity to the vessel wall) immunostaining was used to study major and parenchymal vessels. Collagen IV is Sections (8μm) were incubated overnight at 4°C with monoclonal anti-collagen IV goat anti Collagen-IV (Southern Biotech., USA), and then incubated with species-specific donkey anti-goat FITC conjugated secondary antibody (Jackson Immuno., USA) for overnight at 4°C. Finally, sections were washed and coverslipped.

Morphometry

Analysis was performed by an observer blinded to specimen identity. Quantitative analysis was performed on widefield images obtained under constant illumination and exposure settings using a 20x objective lens (field area 8 ×104 um2, Leica DM 6000 and DFC 350 FX camera).

Major vessel analysis

Brains were removed, preserving the meninges and the circle of Willis at the skull base and 8um coronal sections were immunostained for collagen IV. Collagen-IV immunostained major vessels were photographed and analyzed for wall thickness and internal and external circumference (IPLab, Scanalytic Inc, USA). Collagen-IV immunostained major vessels were photographed and analyzed for wall thickness and internal and external circumference as described previously (5,32}. Briefly, since postfixation distortion of vessel wall shape can alter the measurement of the diameter or radius but does not affect the measurement of circumference. Hence, circumference was measured and diameter was calculated using the relationship circumference/ π. Although all brains were coronally sectioned in a rigid template, a separate potential influence on the measurement of circumference could be minor variations in the angle of histological sectioning. Therefore, in addition to measurement of the internal circumference, the thickness of the blood vessel wall was determined. Thickness was calculated as the average of 4 measurements made at 12, 3, 6, and 9 o’clock in order to minimize the effects of slice angle. Vessel measurements were made for internal carotid artery (ICA), proximal anterior cerebral artery (A1 segment) at bregma +0.0 to 0.38 mm.

Parenchymal vessels

Parenchymal vessels in four brain regions (basal and frontal cerebral cortex, striatum, and hippocampus), separated in right and left hemispheres, were analyzed. 2–3 fields per region per hemisphere were analyzed using IPLab software. Vascular profiles were isolated by intensity threshold segmentation and the number, average area and the area fractions of collagen-IV immunofluorescent vascular profiles were determined. The area fraction, a standard stereological measure, estimates the total amount of a partition as a fraction of total sample volume. The area fraction in this study estimates the total amount of collagen-IV positive tissue as fraction of tissue volume.

Statistics

Each parameter was analyzed by two-way ANOVA (StatView, SAS institute Inc. USA) followed, where appropriate, by Fisher’s PLSD post-hoc t-tests.

Results

This study was divided in two parts; the first part developed and characterized the mouse endovascular model of SAH and compared it with the existing rat SAH model. The second part of study used the mouse endovascular to address the question; does adenosine A2 receptor has a role in early vascular injury after SAH?

Part -One

The mouse endovascular model of SAH

The rat endovascular model of SAH was adapted to mouse.

Physiology

Baseline ICP was 10± 0.8mmHg (mean± sem). At SAH, ICP rose immediately to 61±4 mmHg, thereafter declined slowly and by 60 minutes had reached 36±3 mmHg. (Figure-1, A) Baseline BP was 84±3mmHg. BP increased slightly to 90mmHg at SAH induction and was 78±3mmHg at 60 minutes. It should be noted that in mouse the upper and lower limit of BP for CBF autoregulation are 110 and 40mmHg.3 Baseline CPP was 75±3mmHg. Following SAH induction, CPP fell to 36±6mmHg (48% of the basal values) and remained near this value at 60 minutes.(Figure-1, C) CBF fell to 10±2% of baseline at SAH and had recovered to 36±5 % of baseline 60 minutes later.(Figure-1, D) Please note that in addition to mouse, Figure 1 shows retrospective data of early physiological changes in rat after SAH. This figure is important for a comparison of rat and mouse SAH model; discussed in detail in discussion section.

Figure-1
A comparison of physiological changes after rat and mouse SAH induced via endovascular model

Histological measurements

Internal carotid artery (ICA) and proximal anterior cerebral artery (A1 segment) displayed the similar temporal behavior to SAH; their data were pooled for analysis.

Internal circumference of sham operated WT animals sacrificed at 1 or 3 hours after surgery remained unchanged but had decreased 15% at 6 hours (Figure-3A, P=0.044). In contrast, a significant time dependent reduction of internal circumference of WT mice occurred after SAH (Figure3B, F=38.6, P<0.001). Internal circumference decreased to 51% at 1 hour and recovered thereafter, reaching approximately 70% of time matched sham cohort 6 hours after SAH. Previously, we have found similar reductions in internal circumference of major vessels (ICA: 51%, A2 segment: 52%) in rat model one hour after SAH. 5

Figure-3Figure-3
Internal circumference of Major cerebral vessels in WT and A2AR-KO after SAH

Wall thickness of ICA and A1 segment of anterior cerebral artery increased significantly after SAH as compared to sham -operated animals (F=10.3, P=0.0017; data not shown). At 1 hour after SAH wall thickness was 149 % and decreased there after reaching 111% of time matched sham at 6 hours.

Part-2

A2AR-knockout mice

The initial peak ICP and minimum CPP values after SAH were similar in the knockouts and in WT animals (figure-2). However, from thereon small difference in ICP values at all times was observed, mean ICP was lower in knockouts than in WT mice, however, this difference reached significance only at 20 minutes. Similarly, CPP values at 10 min and beyond were significantly different between the two groups, with the knockouts showing values nearer to baseline than the WT, however, this difference reached significance only at 60 minutes. CBF fell to a significantly lower value in knockouts, however exhibited a similar trend of recovery as for ICP and CPP. BP appeared to be unaffected by the knockout.

Figure-2
A comparison of physiological changes after SAH in WT and A2AR-KO

Major cerebral vessels

Internal circumference of major cerebral vessels in sham operated A2AR-KO sacrificed at 3 hours was similar to their time matched WT sham cohorts. After SAH a significant time dependent reduction in internal circumference of major cerebral vessels was found in A2AR-KO mice after SAH (Figure 3B, F=11.3, P=0.001). Internal circumference decreased to 80% at 1hr after SAH, remained near this value at 3 hours, and then decreased further, reaching approximately 60% of the sham values at 6 hours post SAH.

Compared to WT mice the degree of reduction in internal circumference of major cerebral arteries after SAH was significantly smaller in A2AR-KO (F=8.7, P=0.004). This difference was significant at 1hour (F=22, P=0.0001), and a 3 hours (F=5.09; P=0.03). At 6 hours after SAH no difference in internal circumference of major cerebral arteries after SAH was found (F=0.48, P=0.49; figure 3B).

Wall thickness

Compared to sham-operated A2AR-KO mice the wall thickness of major cerebral arteries increased significantly after SAH as (F=4.5, P=0.03). At 1hr, wall thickness increased to 141 % and decreased thereafter reaching a value not significantly different then sham (91±4.7 %) at 6 hours after SAH. Increase in the wall thickness of major cerebral artery in KO was similar to that of WT at all time points after SAH (F=0.001, P=0.9; data not shown).

Collagen-IV immunofluorescence

Wild type mice

As reported previously for rats, in sham operated WT mice collagen-IV immunostaining clearly delineated both large vessels and the microvasculature. After SAH, parenchymal vessels appeared as interrupted sequences of segments instead of continuous profiles (Figure 4A). This staining pattern was present across the two hemispheres and in all brain regions; hence for quantification all measurements were pooled and shown as percent sham. In WT mice, collagen-IV immunostaining was decreased to 90% of normal area at 1 hour survival, the first time point assayed. Collagen-IV area decreased further to 70% of normal at 6 hours survival.(Figure 4B)

Figure-4Figure-4
Collagen-IV immunostaining of parenchymal microvessels is reduced after SAH

Adenosine A2A receptor knockout mice

In contrast to the early reduction in collagen-IV immunostaining in the WT mice, the area fraction of collagen-IV immunostaining in the KO remained at normal levels at 1 and 3 hours survival. Immunostaining was reduced at 6 hours survival to 80 % of normal, a value significantly greater than the 6 hour WT value. ANOVA compared to WT (F= 25.1, P<0.001), post hoc test; P<0.05 at all time points examined. No hemispheric or brain regional difference in collagen IV straining in sham or SAH animals was observed.

These data indicate that the A2A receptor knockout reduces microvessel degradation after SAH. (Figure 4A and B)

Discussion

This study adapted the rat endovascular model of SAH to mouse and investigated the role of adenosine A2A receptor in ischemic vascular injury after SAH. In WT mice, temporal changes in wall thickness and internal diameter of major cerebral vessels and in microvascular collagen-IV were similar to those we have found in the rat.5,34 However, in A2A receptor knockout mice these changes were reduced in intensity.

Existing Mouse models of SAH

Two variations of mouse experimental SAH models exist; endovascular puncture models 15,27 and injection models (injection of autologous blood into the subarachnoid space) 17,20. Neither model record early physiological changes after SAH. Physiological data are important in interpreting the results of SAH experiments for a number of reasons: 1. Control of blood pressure and blood gases are required to assure that ischemic and other cerebral changes are due to the hemorrhage itself rather then systemic causes. 2. We and others have demonstrated that early alteration of CBF is one of the critical determinants of outcome after SAH 5,29. CBF is highly correlated with ischemic glutamate release during the last 60 minutes after SAH and predicts 24 hr survival 5. CBF reduction can be attenuated pharmacologically to reduce glutamate release 32. 3. Increased ICP at the time of SAH registers the event. When the rise in ICP is not confirmed there is no way of knowing if an SAH occurred when the animal is sacrificed at later time points, particularly in experiments that do not utilize histological analysis. The degree of elevation of ICP provides information regarding the intensity of the bleed 30, which permits stratification according to SAH intensity 5. For these reasons physiological measurements in a mouse model of SAH provides an important tool in understanding SAH pathophysiology

The mouse endovascular SAH model: physiological changes and comparison with the rat

The value of ICP peak in the present endovascular mouse SAH model falls into moderately severe in the rat.5 A comparison of early physiological changes between mouse and rats that received SAH of similar intensity induced via similar method (Figure-1) indicates no difference in CBF and BP during the first 60 minutes, however, a quite different pattern of ICP decline after reaching a peak. The pattern of decline ICP is important as it affects CPP. Two patterns of ICP declines are noted in humans, dogs, and baboons: 1) a fast decline (within 5 minutes) to a plateau at a value near the basal values and 2) a slow decline followed by a plateau to a value higher than the basal value.2,16 We have previously found the first pattern of ICP decay in the rat endovascular model of SAH and now document the second pattern of ICP decay pattern in the mouse. It is important to note that, in the first pattern, as ICP returns to near basal values, so does the CPP; however, in the second pattern, depending upon the value of ICP plateau, CPP remains reduced. As a consequence of the ICP pattern, CPP at 60 minutes after SAH recovers to approximately 80% of baseline in rat, and only 48% of baseline in mouse. Substantial CPP reduction in the mouse after SAH would be an additional factor contributing in alterations in cerebral microcirculation. The persistent elevation of ICP (pattern II) has been attributed to the occurrence of cisternal hematoma that would make recirculation impossible and create a clinical picture of brain death. This ICP pattern is considered responsible of the wide distribution of the necrotic foci in human SAH seen at autopsy that could not be ascribed to cerebral vasospasm.2

The mouse endovascular SAH model; major and parenchymal vessel injury

We have found changes in major and parenchymal vessels in WT mice that are similar to those previously documented in the rat after SAH.5,34 In this study changes in internal diameter and wall thickness of major cerebral vessels occur as early as one hour after SAH and have begun to recover to the basal level by 6 hours, the last time interval examined in this study. Previous studies show similar changes in major cerebral vessels in rat after SAH.5 The loss of the major basal lamina protein, collagen-IV, had already began at one hour after SAH and continued at 6 hours. We have previously described a similar temporal profile of collagen-IV loss in rat after SAH.34 These results strengthen our previous finding and establish cross specie similarity in early effects of SAH on cerebral vessels.

Adenosine A2A receptors knock out mice and major and parenchymal vessel injury after SAH

Our results indicate that A2AR-KO animals are more resistant to vascular changes and injury after SAH then the WT mice. Although constriction of major cerebral vessels and reduction in collagen IV area fraction of parenchymal vessels occurred in both A2AR-KO and WT mice, the temporal profile and intensity of their development was different. For example: at 1 and 3 hours after SAH internal diameter of major vessels had reduced by 20 % in A2AR-KO and by 50–60% in WT cohorts. Similarly, the area fraction of collagen IV decreased only at 6 hours after SAH in A2AR-KO but had already reduced at one hour in the wild types. This result indicates that absence of functional A2AR attenuates brain vascular injury during the early hours of SAH.

The contribution of A2A receptors in other forms of cerebral ischemic injury is studied with mixed results. Some investigators find A2A receptor activation beneficial1,35 and others harmful to the ischemic brain.7,13,14,22,28 This may be due to the lack of selectivity of the pharmacological agents used. Most A2A receptor antagonists and agonist act on all adenosine receptor subtype with different affinities.24,26 Although, affinity based discrimination are achievable with in vitro studies, selectivity is more difficult with in vivo studies due to the high dose requirements. The use of genetically manipulated animals is a research strategy which avoids pharmacological pitfalls.

Using a middle cerebral artery model of cerebral ischemia Chen at al., have demonstrated that global A2A receptor inactivation reduces infarct volume and improves neurological behavioral deficit score.9 More recently, the same group generated chimeric mice by selectively inactivating or reconstituting A2A receptors into knockout or wild-type littermates and assessed response to cerebral ischemic injury.38 They found that selective inactivation of A2A receptors attenuates infarct volumes and ischemia-induced expression of several proinflammatory cytokines and their selective reconstitution reinstates ischemic brain injury. The results from our study indicate that protection against the early vascular changes is yet another mechanism of attenuated cerebral injury in the absence of functional A2A receptors. Lastly, Miekisiak et al have demonstrated significant attenuation of CBF during transient (30 seconds) of hypoxia in A2AR-KO as compared to WT animals.21

We speculate that A2AR-KO mice are resistant to post-SAH change in vessel diameter and basal lamina because the absence of functional A2A receptors allows expression of vaso-protective mechanisms. One mechanism may be the lack of desensitization of A1 receptors by A2A receptor in A2AR-KO mice. A number of studies demonstrate that A1 receptors are desensitized and down regulate by A2A receptors and their response11,19, and hence selective inhibition of A2A receptors would attenuate ischemic injury.14

Another mechanism may involve A2B receptors. A2B receptors are present in small number on vascular smooth muscle and have vasodilator properties. In the absence of functional A2AR in our KO animals, adenosine concentrations may be elevated. The increased concentrations of adenosine after SAH in the A2AR-KO animals would lead to activation of the less sensitive A2B receptors. Alternatively, A2B activation might becomes more pronounced in the absence of functional A2A receptors. Either mechanism, increased adenosine concentrations in KO mice or increased activation of A2B receptors, could account for the reduced collagen loss after SAH in A2AR KO mice. We have previously demonstrated that matrix metalloproteinase-9 (a collagenase;MMP-9) is involved in collagen-IV destruction after SAH.33,34 A recent study demonstrates that during hypoxia activation of A2B receptors lead to inhibition of MMP-9 production in monocyte-derived dendritic cells required for their transfer across extracellular matrix.39

Similarity in physiology but not in vascular effects of SAH in WT and A2AR mice

It should be noted that in this study the intensity of alterations of major and parenchyma vessel after SAH varied between the two genotypes while only small difference in the physiological parameters were found. More specifically, the peak rise and 60 minute decline in ICP, 60 minute recovery in CBF, and initial fall in CPP were comparable among the WT and A2AR-KO mice indicating similar intensity of injury but the degree of reduction in major vessels diameter and the denudation of collagen-IV of parenchymal vessels basal lamina varied. This disparity between physiology and vascular response indicates contribution of additional mechanisms in vascular injury after SAH. Moreover, the similarity in the magnitude of CBF reduction, but not in the diameter of major vessels between the two mouse strains indicates that mere reduction in major vessel diameter can not explain circulation deficits after SAH. Other contributing mechanisms may include; reduced cerebral nitric oxide level, aggregation of platelets in microvessels, release and activation of vascular collagenases such as matrix metalloproteinases 9 (MMP-9), and etc.31

Conclusion

Absence of functional A2AR decreases ICP and increases CPP, reduces the constriction of major vessels, and reduces the loss of microvascular collagen-IV after SAH. These results suggest that adenosine signaling plays a role in vascular dynamics and microvascular injury in the period immediately following SAH and, further, that early inhibition of adenosine A2A receptors after SAH may prove beneficial.

Footnotes

Apart of this study was presented in poster form in 2008 meeting of Society of Neuroscience.

References

1. Aden U, Halldner L, Lagercrantz H, Dalmau I, Ledent C, Fredholm BB. Aggravated brain damage after hypoxic ischemia in immature adenosine A2A knockout mice. Stroke. 2003;34:739–744. [PubMed]
2. Asano T, Sano K. Pathogenetic role of no-reflow phenomenon in experimental subarachnoid hemorrhage in dogs. J Neurosurg. 1977;46:454–466. [PubMed]
3. Ayata C, Dunn AK, Gursoy OY, Huang Z, Boas DA, Moskowitz MA. Laser speckle flowmetry for the study of cerebrovascular physiology in normal and ischemic mouse cortex. J Cereb Blood Flow Metab. 2004;24:744–755. [PubMed]
4. Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke. 1995;26:1086–1091. [PubMed]
5. Bederson JB, Levy AL, Ding WH, Kahn R, DiPerna CA, Jenkins ALr, et al. Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery. 1998;42:352–360. [PubMed]
6. Boison D. Adenosine as a neuromodulator in neurological diseases. Curr Opin Pharmacol. 2008;8:2–7. [PMC free article] [PubMed]
7. Bona E, Aden U, Gilland E, Fredholm BB, Hagberg H. Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists. Neuropharmacology. 1997;36:1327–1338. [PubMed]
8. Britz GW, Meno JR, Park IS, Abel TJ, Chowdhary A, Nguyen TS, et al. Time-dependent alterations in functional and pharmacological arteriolar reactivity after subarachnoid hemorrhage. Stroke. 2007;38:1329–1335. [PubMed]
9. Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, et al. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci. 1999;19:9192–9200. [PubMed]
10. Chen JF, Sonsalla PK, Pedata F, Melani A, Domenici MR, Popoli P, et al. Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and “fine tuning” modulation. Prog Neurobiol. 2007;83:310–331. [PubMed]
11. Ferre S, Ciruela F, Borycz J, Solinas M, Quarta D, Antoniou K, et al. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain. Front Biosci. 2008;13:2391–2399. [PubMed]
12. Fuxe K, Ferre S, Genedani S, Franco R, Agnati LF. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav. 2007;92:210–217. [PubMed]
13. Gao Y, Phillis JW. CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. Life Sci. 1994;55:PL61–65. [PubMed]
14. Higashi H, Meno JR, Marwaha AS, Winn HR. Hippocampal injury and neurobehavioral deficits following hyperglycemic cerebral ischemia: effect of theophylline and ZM 241385. J Neurosurg. 2002;96:117–126. [PubMed]
15. Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A, et al. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke. 1999;30:867–871. discussion 872. [PubMed]
16. Kamiya K, Kuyama H, Symon L. An experimental study of the acute stage of subarachnoid hemorrhage. J Neurosurg. 1983;59:917–924. [PubMed]
17. Lin CL, Calisaneller T, Ukita N, Dumont AS, Kassell NF, Lee KS. A murine model of subarachnoid hemorrhage-induced cerebral vasospasm. J Neurosci Methods. 2003;123:89–97. [PubMed]
18. Lin CL, Shih HC, Lieu AS, Lee KS, Dumont AS, Kassell NF, et al. Attenuation of experimental subarachnoid hemorrhage--induced cerebral vasospasm by the adenosine A2A receptor agonist CGS 21680. J Neurosurg. 2007;106:436–441. [PubMed]
19. Lopes LV, Cunha RA, Ribeiro JA. Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol. 1999;82:3196–3203. [PubMed]
20. Matz PG, Copin JC, Chan PH. Cell death after exposure to subarachnoid hemolysate correlates inversely with expression of CuZn-superoxide dismutase. Stroke. 2000;31:2450–2459. [PubMed]
21. Miekisiak G, Kulik T, Kusano Y, Kung D, Chen JF, Winn HR. Cerebral blood flow response in adenosine 2a receptor knockout mice during transient hypoxic hypoxia. J Cereb Blood Flow Metab. 2008;28:1656–1664. [PubMed]
22. Monopoli A, Lozza G, Forlani A, Mattavelli A, Ongini E. Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. Neuroreport. 1998;9:3955–3959. [PubMed]
23. Moore CC, Martin EN, Lee GH, Obrig T, Linden J, Scheld WM. An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models. BMC Infect Dis. 2008;8:141. [PMC free article] [PubMed]
24. Ngai AC, Coyne EF, Meno JR, West GA, Winn HR. Receptor subtypes mediating adenosine-induced dilation of cerebral arterioles. Am J Physiol Heart Circ Physiol. 2001;280:H2329–2335. [PubMed]
25. O’Regan M. Adenosine and the regulation of cerebral blood flow. Neurol Res. 2005;27:175–181. [PubMed]
26. Ongini E, Dionisotti S, Gessi S, Irenius E, Fredholm BB. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1999;359:7–10. [PubMed]
27. Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol Res. 2002;24:510–516. [PubMed]
28. Pedata F, Gianfriddo M, Turchi D, Melani A. The protective effect of adenosine A2A receptor antagonism in cerebral ischemia. Neurol Res. 2005;27:169–174. [PubMed]
29. Prunell GF, Mathiesen T, Diemer NH, Svendgaard NA. Experimental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery. 2003;52:165–175. discussion 175-166. [PubMed]
30. Schwartz AY, Masago A, Sehba FA, Bederson JB. Experimental models of subarachnoid hemorrhage in the rat: A refinement of the endovascular filament model. J Neurosci Methods. 2000;96:161–167. [PubMed]
31. Sehba FA, Bederson JB. Mechanisms of Acute Brain injury after Subarachnoid Hemorrhage. Neurol Res. 2006;28:381–398. [PubMed]
32. Sehba FA, Ding WH, Chereshnev I, Bederson JB. Effects of S-nitrosoglutathione on acute vasoconstriction and glutamate release after subarachnoid hemorrhage. Stroke. 1999;30:1955–1961. [PubMed]
33. Sehba FA, Makonnen G, Friedrich V, Bederson JB. Acute cerebral vascular injury occurs after subarachnoid hemorrhage and can be prevented by administration of a Nitric Oxide donor. J Neurosurg. 2007;106:321–329. [PubMed]
34. Sehba FA, Mostafa G, Knopman J, Friedrich V, Jr., Bederson JB. Acute alterations in Microvascular basal lamina after Subarachnoid Hemorrhage. J Neurosurg. 2004;101:633–640. [PubMed]
35. Sheardown MJ, Knutsen LJS. Unexpected neuroprotection observed with the adenosine A2a receptor agonist CGS21680. Drug Develop. Res. 1996;39:108–114.
36. Sullivan GW, Fang G, Linden J, Scheld WM. A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. J Infect Dis. 2004;189:1897–1904. [PubMed]
37. Winn HR, Rubio R, Berne RM. Brain adenosine production in the rat during 60 seconds of ischemia. Circ Res. 1979;45:486–492. [PubMed]
38. Yu L, Huang Z, Mariani J, Wang Y, Moskowitz M, Chen JF. Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury. Nat Med. 2004;10:1081–1087. [PubMed]
39. Zhao P, Li XG, Yang M, Shao Q, Wang D, Liu S, et al. Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway. Mol Immunol. 2008;45:2187–2195. [PubMed]